Immuno-Oncology 360°

Wednesday, March 16, 2022 - 07:30 to Friday, March 18, 2022 - 16:00 (GMT-4)

The 8th Annual Immuno-Oncology 360° Delivers Three Key Benefits:

- Access to KOLs driving the science
- Partnership opportunities with all stakeholders in Immuno-Oncology
- Presentations on the latest data impacting the science, clinical and business advancements in Immuno-Oncology

2022 Key Topic Areas
- Discovery/Preclinical Science
- Cell and Gene Therapy
- Translational Science
- Bispecifics
- Clinical Developments
- Neoadjuvant/Adjuvant Data
- Emerging Biomarkers
- Cytokines
- Clinical Operations
- IO Combinations
- Imaging Advancements
- Business Developments

Immuno-Oncology 360° reports on the most current data and rapid advancements to help IO stakeholders:
- Be at the forefront of the most relevant research and developments from key leadership who are at the pulse of cancer immunotherapy
- Foster collaboration amongst those working in all aspects of cancer immunotherapy together under one roof
- Partner to expand technology platforms to develop therapeutics at an accelerated rate
- Receive the latest pre-clinical, translational and clinical data from academia and industry
- Create and prioritize strategies targeted toward specific tumor types
- Identify and gain a greater understanding of what assets are available for potential combinations
- Hear from IO clinical trial leaders as they cover trial design, clinical operations, the latest outcomes and lessons learned
- Get key investor and analyst evaluations and insights on the IO landscape, challenges and what's next
- Learn about biomarker advancements in vaccines, imaging, neoantigen approaches and more
- Obtain coverage on a wide range of emerging technologies

Event Information

The Conference Forum
New York Marriott at the Brooklyn Bridge
333 Adams Street
Brooklyn, NY 11201
United States
This event is under the auspices of UICC
Last update: 
Wednesday 26 January 2022